$NVAX.US$ Novavax does have many things in the pipeline to j...

Novavax does have many things in the pipeline to justify it's price target from 5 analysts of $31.
From Rocco on Yahoo finance,
"Novavax 2 billion market cap
they just starting shipping a cobranded malaria drug that appears set to dominate that space..last year there were 250 million cases of malaria and they said last year that they want to address that entire market
second...the are set to give an alternative to mrna ,albeit small but even 5-10% would be massive for them
third Sanofi is basically going to re brand Novavaxs covid offering and then sell it worldwide with double digit royalties
fourth and most important Sanfi can use Matrix m in all of their offerings and pay mid single digit royalties

so looking at what they do have its pretty impressive and while it does not show a moderna or pfizer like market cap ..it certainly should mean at least a 10 billion market cap..keep in mind royalties are like gold pure profit not offset by product costs
just an opinion"